Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tapering Antipsychotics in Patients With Remitted Psychosis: From Bedside to Bench Employing Animal Model and N-Acetylcysteine Study and Back to Bedside

NCT06546475 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06546475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06546475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tapering Antipsychotics in Patients With Remitted Psychosis: From Bedside to Bench Employing Animal Model and N-Acetylcysteine Study and Back to Bedside
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 1, 2024
Completion date
July 31, 2027
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis